These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 10918572

  • 1. Unique carboxyl-terminal sequences of wild type and alternatively spliced variant forms of transforming growth factor-alpha precursors mediate specific interactions with ErbB4 and ErbB2.
    Xu X, Kelleher KF, Liao J, Creek KE, Pirisi L.
    Oncogene; 2000 Jun 29; 19(28):3172-81. PubMed ID: 10918572
    [Abstract] [Full Text] [Related]

  • 2. Human keratinocytes and tumor-derived cell lines express alternatively spliced forms of transforming growth factor-alpha mRNA, encoding precursors lacking carboxyl-terminal valine residues.
    Xu X, Liao J, Creek KE, Pirisi L.
    Oncogene; 1999 Sep 30; 18(40):5554-62. PubMed ID: 10523832
    [Abstract] [Full Text] [Related]

  • 3. Neuregulin-1 only induces trans-phosphorylation between ErbB receptor heterodimer partners.
    Li Z, Mei Y, Liu X, Zhou M.
    Cell Signal; 2007 Mar 30; 19(3):466-71. PubMed ID: 16978839
    [Abstract] [Full Text] [Related]

  • 4. Ligands for ErbB-family receptors encoded by a neuregulin-like gene.
    Chang H, Riese DJ, Gilbert W, Stern DF, McMahan UJ.
    Nature; 1997 May 29; 387(6632):509-12. PubMed ID: 9168114
    [Abstract] [Full Text] [Related]

  • 5. ErbB kinases and NDF signaling in human prostate cancer cells.
    Grasso AW, Wen D, Miller CM, Rhim JS, Pretlow TG, Kung HJ.
    Oncogene; 1997 Nov 27; 15(22):2705-16. PubMed ID: 9400997
    [Abstract] [Full Text] [Related]

  • 6. Role of the C-terminal linear region of EGF-like growth factors in ErbB specificity.
    van der Woning SP, Venselaar H, van Rotterdam W, Jacobs-Oomen S, van Leeuwen JE, van Zoelen EJ.
    Growth Factors; 2009 Jun 27; 27(3):163-72. PubMed ID: 19384683
    [Abstract] [Full Text] [Related]

  • 7. Expression of erythroblastic leukemia viral oncogene homolog (erbBS) mRNAs and possible splice variants in 3T3-L1 preadipocytes.
    Pagano E, Fontana V, Calvo JC.
    Mol Med Rep; 2011 Jun 27; 4(5):955-61. PubMed ID: 21720714
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Widespread expression of ErbB2, ErbB3 and ErbB4 in non-human primate brain.
    Thompson M, Lauderdale S, Webster MJ, Chong VZ, McClintock B, Saunders R, Weickert CS.
    Brain Res; 2007 Mar 30; 1139():95-109. PubMed ID: 17280647
    [Abstract] [Full Text] [Related]

  • 10. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors.
    Alimandi M, Wang LM, Bottaro D, Lee CC, Kuo A, Frankel M, Fedi P, Tang C, Lippman M, Pierce JH.
    EMBO J; 1997 Sep 15; 16(18):5608-17. PubMed ID: 9312020
    [Abstract] [Full Text] [Related]

  • 11. Expression of ErbB receptor proteins and TGF-alpha during diethylnitrosamine-induced hepatocarcinogenesis in the rat liver.
    Lee TY, Kim KT, Han SY.
    Korean J Hepatol; 2007 Mar 15; 13(1):70-80. PubMed ID: 17380077
    [Abstract] [Full Text] [Related]

  • 12. Epidermal growth factor mutant with wild-type affinity for both ErbB1 and ErbB3.
    Wingens M, Jacobs-Oomen S, van der Woning SP, Stortelers C, van Zoelen EJ.
    Biochemistry; 2006 Apr 11; 45(14):4703-10. PubMed ID: 16584205
    [Abstract] [Full Text] [Related]

  • 13. Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients.
    Junttila TT, Laato M, Vahlberg T, Söderström KO, Visakorpi T, Isola J, Elenius K.
    Clin Cancer Res; 2003 Nov 01; 9(14):5346-57. PubMed ID: 14614020
    [Abstract] [Full Text] [Related]

  • 14. Activation of erbB2 and c-src in phorbol ester-treated mouse epidermis: possible role in mouse skin tumor promotion.
    Xian W, Rosenberg MP, DiGiovanni J.
    Oncogene; 1997 Mar 27; 14(12):1435-44. PubMed ID: 9136987
    [Abstract] [Full Text] [Related]

  • 15. Differential nuclear localization and kinase activity of alternative ErbB4 intracellular domains.
    Sundvall M, Peri L, Määttä JA, Tvorogov D, Paatero I, Savisalo M, Silvennoinen O, Yarden Y, Elenius K.
    Oncogene; 2007 Oct 18; 26(48):6905-14. PubMed ID: 17486069
    [Abstract] [Full Text] [Related]

  • 16. Compensatory ErbB3/c-Src signaling enhances carcinoma cell survival to ionizing radiation.
    Contessa JN, Abell A, Mikkelsen RB, Valerie K, Schmidt-Ullrich RK.
    Breast Cancer Res Treat; 2006 Jan 18; 95(1):17-27. PubMed ID: 16267617
    [Abstract] [Full Text] [Related]

  • 17. The neuregulin-I/ErbB signaling system in development and disease.
    Britsch S.
    Adv Anat Embryol Cell Biol; 2007 Jan 18; 190():1-65. PubMed ID: 17432114
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of transforming growth factor alpha (TGF-alpha)-mediated growth effects in ovarian cancer cell lines by a tyrosine kinase inhibitor ZM 252868.
    Simpson BJ, Bartlett JM, Macleod KG, Rabiasz G, Miller EP, Rae AL, Gordge P, Leake RE, Miller WR, Smyth J, Langdon SP.
    Br J Cancer; 1999 Mar 18; 79(7-8):1098-103. PubMed ID: 10098742
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.